- Home
- ATNM vs DSY Comparison
ATNM vs DSY Comparison
Compare ATNM & DSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- DSY
- Stock Information
- Founded
- ATNM 2000
- DSY 2020
- Country
- ATNM United States
- DSY China
- Employees
- ATNM N/A
- DSY N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- DSY
- Sector
- ATNM Health Care
- DSY
- Exchange
- ATNM Nasdaq
- DSY Nasdaq
- Market Cap
- ATNM 50.2M
- DSY 57.6M
- IPO Year
- ATNM N/A
- DSY N/A
- Fundamental
- Price
- ATNM $1.63
- DSY $1.61
- Analyst Decision
- ATNM Strong Buy
- DSY
- Analyst Count
- ATNM 2
- DSY 0
- Target Price
- ATNM $4.50
- DSY N/A
- AVG Volume (30 Days)
- ATNM 130.6K
- DSY 3.9M
- Earning Date
- ATNM 11-13-2025
- DSY 01-01-0001
- Dividend Yield
- ATNM N/A
- DSY N/A
- EPS Growth
- ATNM N/A
- DSY 120.37
- EPS
- ATNM N/A
- DSY 0.01
- Revenue
- ATNM N/A
- DSY $7,323,356.00
- Revenue This Year
- ATNM N/A
- DSY N/A
- Revenue Next Year
- ATNM N/A
- DSY N/A
- P/E Ratio
- ATNM N/A
- DSY $144.47
- Revenue Growth
- ATNM N/A
- DSY 16.37
- 52 Week Low
- ATNM $1.03
- DSY $0.95
- 52 Week High
- ATNM $2.41
- DSY $7.33
- Technical
- Relative Strength Index (RSI)
- ATNM 46.73
- DSY 55.08
- Support Level
- ATNM $1.52
- DSY $1.51
- Resistance Level
- ATNM $1.70
- DSY $7.33
- Average True Range (ATR)
- ATNM 0.07
- DSY 0.47
- MACD
- ATNM -0.01
- DSY 0.08
- Stochastic Oscillator
- ATNM 36.71
- DSY 9.92
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About DSY Big Tree Cloud Holdings Limited Ordinary Shares
Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.